The picture of chronic liver diseases (CLDs) has changed considerably in recent years. One
of them is the increase of non-alcoholic fatty liver disease. More and more CLD patients …

Background Recent advances in evaluation of body composition show body mass index to
be inadequate in differentiating between body compartments in cirrhosis. Given the …

Background & aims The quantity and quality of skeletal muscle and adipose tissue is an
important prognostic factor for clinical outcomes across several illnesses. Clinically acquired …

Background & Aims Sarcopenia and myosteatosis are associated with advanced
nonalcoholic fatty liver disease (NAFLD). However, muscle alterations in early stage NAFLD …

Background Sarcopenia and myosteatosis have been associated to a poor prognosis of
cirrhosis and to a higher incidence of hepatic encephalopathy (HE). The prognostic …

Background & Aims Body composition, particularly sarcopenia, is associated with mortality
in patients with decompensated cirrhosis undergoing transplant evaluation. Similar data are …

Abstract Background & Aim Anthropometric data are associated with nonalcoholic fatty liver
disease (NAFLD) development and progression. We investigated whether the quantity and …

Obesity is a major driving factor in the incidence, progression, and poor treatment response
in gastrointestinal cancers. Herein, we conducted a comprehensive analysis of the impact of …

Background/objectives Malnutrition coexisting with abdominal adipose tissue accumulation
bring a double burden on prognosis. More recently, the Global Leadership Initiative on …

Chronic liver disease is a major cause of morbidity and mortality worldwide. Epidemiology,
clinical phenotype and response to therapies for gastrointestinal and liver diseases are …